i took tirzepatide while pregnant and Pregnancy: Safety, Risks, and Clinical Guidance Tirzepatide and Pregnancy: Safety Facts

Mounjaro is typically prescribed for individuals with a BMI of 30 or higher (obesity), or a BMI of 27 or higher if accompanied by conditions like type 2 diabetes , high blood pressure, or high cholesterol

Clinical evidence from the STEP trials showed that participants achieving the 2.4 mg maintenance dose experienced approximately 1517% body weight reduction over 68 weeks compared to placebo

Glutamate dehydrogenases in neisseria meningitidis

Patients with a history of retinopathy should be monitored by their provider and ophthalmologist during treatment

In people with polycystic ovary syndrome (PCOS), these effects might be stronger, because their cycles are already irregular

GLP-1 Receptor Activation: Increases insulin release, suppresses glucagon production, and promotes satiety